Norden Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.77M Sell
28,315
-195,574
-87% -$12.4M 0.13% 131
2026
Q2
$12.9M Buy
223,889
+23,065
+11% +$1.32M 1.06% 15
2026
Q1
$12.2M Buy
200,824
+23,909
+14% +$1.39M 1.17% 12
2025
Q4
$9.5M Buy
176,915
+157,604
+816% +$7.58M 0.93% 17
2025
Q3
$871K Sell
19,311
-375
-2% -$17.5K 0.09% 221
2025
Q2
$911K Sell
19,686
-73,134
-79% -$3.59M 0.1% 202
2025
Q1
$5.66M Buy
92,820
+744
+0.8% +$43.4K 0.65% 27
2024
Q4
$5.21M Buy
92,076
+70,423
+325% +$3.93M 0.59% 33
2024
Q3
$1.12M Buy
21,653
+11,158
+106% +$523K 0.13% 170
2024
Q2
$436K Sell
10,495
-3,351
-24% -$150K 0.09% 240
2024
Q1
$751K Buy
13,846
+3,213
+30% +$164K 0.15% 153
2023
Q4
$546K Buy
10,633
+773
+8% +$40.6K 0.09% 137
2023
Q3
$572K Buy
+9,860
New +$604K 0.19% 121

Other funds holding BMY

Norden Group's BMY Position: Q3 2026 in Review

Norden Group reduced its Bristol-Myers Squibb (BMY) stake by 87% in Q3 2026, selling an estimated $12.4M and leaving 28,315 shares worth $1.77M. The position accounts for 0.13% of the portfolio, ranked #131.

Norden Group first reported a position in BMY in Q3 2023 and has held it in 13 quarters since. The position peaked at $12.9M in Q2 2026. 2,555 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Norden Group held 28,315 shares of Bristol-Myers Squibb worth $1.77M as of Q3 2026.
  • Norden Group sold 195,574 Bristol-Myers Squibb shares in Q3 2026, an estimated $12.4M.
  • Bristol-Myers Squibb made up 0.13% of Norden Group's portfolio in Q3 2026, its #131 holding.
  • Norden Group first reported a position in Bristol-Myers Squibb in Q3 2023 and has held it in 13 quarters since.
  • Norden Group's Bristol-Myers Squibb position peaked at $12.9M in Q2 2026.
  • 2,555 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Norden Group's 13F filing for Q3 2026, filed 20 Oct 2026.